KT Tape, a company that deals with drug-free pain relief, has launched its KT Recovery+ Wave, it was reported on Monday.
The company says that the product is a clinically proven and FDA approved wearable device that offers drug-free pain relief for sports injuries, knee pain, arthritis, back pain, carpal tunnel, sprains and more.
The new KT Recovery+ Wave utilises sensation-free electromagnetic pulses called pulsed shortwave therapy to decrease nerve hypersensitivity and relieve pain. It has a guaranteed battery life of 250 hours and is available at an MSRP of USD34.99.
Bio-Thera reports promising BAT8008 - BAT1308 combination lung cancer clinical data at ESMO 2026
Alnylam reports positive Phase 1b results for brezosiran in Huntington's disease
Zai Lab reports promising Phase 1b results for zocilurtatug pelitecan in small cell lung cancer
HUYABIO International reports positive Phase 3 trial results for HBI-8000 and nivolumab combination
ImmunoForge to participate in BIO-Europe 2026
IHI and Bristol Myers Squibb launch initiative to expand cancer clinical trial access
European Commission approves Novartis' Cosentyx for polymyalgia rheumatica
Edwards Lifesciences wins FDA approval for PASCAL Precision tricuspid repair system
Five-year US study highlights long-term effectiveness of ViiV Healthcare's Cabenuva
Summit Therapeutics and ECOG-ACRIN launch Phase II/III trial collaboration for biliary tract cancer
Abbott secures CE Mark for Cologuard Plus in Europe
Solventum's combined use of Restrata Matrix and Solventum VAC Therapy receives FDA 510(k) clearance
Oracle partners AstraZeneca for AI-enabled healthcare innovation